nach oben

Die Ophthalmologie

Erschienen in:

04.03.2024 | Vitrektomie | Leitthema

Bakterielle endogene Endophthalmitis

Erregerspektrum und medikamentöse Therapie

verfasst von: Prof. Dr. Thomas Ness

Erschienen in: Die Ophthalmologie | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Zusammenfassung

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der bakteriellen endogenen Endophthalmitis sind sowohl grampositive als auch gramnegative Keime nachweisbar. Häufige Quellen sind eine Endokarditis, ein gastrointestinaler oder urogenitaler Eingriff, ein venöser Venenverweilkatheter, ein Leberabszess, eine Haut- oder Weichteilinfektion, eine Meningitis oder seltener ein intravenöser Drogenabusus. Die Therapie besteht aus einer systemischen und intraokularen Gabe von Antibiotika und einer Vitrektomie. Systemische oder intraokulare Kortikosteroide können zusätzlich erwogen werden.

Aboltins CA, Allen P, Daffy JR (2005) Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral candida species. Med J Aust 182:427CrossRefPubMed

Adam CR, Sigler EJ (2014) Multimodal imaging findings in endogenous aspergillus endophthalmitis. Retina 34:1914–1915. https://doi.org/10.1097/IAE.0000000000000135CrossRefPubMed

Ang M, Jap A, Chee SP (2011) Prognostic factors and outcomes in endogenous Klebsiella pneumoniae endophthalmitis. Am J Ophthalmol 151:338–44 e2. https://doi.org/10.1016/j.ajo.2010.08.036CrossRefPubMed

Aoyama Y, Oba Y, Hoshide S et al (2019) The early diagnosis of endophthalmitis due to group B streptococcus infective endocarditis and its clinical course: a case report and literature review. Intern Med 58:1295–1299. https://doi.org/10.2169/internalmedicine.2232-18CrossRefPubMedPubMedCentral

Arevalo JF, Jap A, Chee S‑P, Zeballos DG (2010) Endogenous endophthalmitis in the developing world. Int Ophthalmol Clin 50:173–187. https://doi.org/10.1097/IIO.0b013e3181d26dfcCrossRefPubMed

Arici C, Aras C, Tokman HB, Torun MM (2016) An in vitro experimental study on the antimicrobial activity of silicone oil against anaerobic bacteria. Ocul Immunol Inflamm 24:173–177. https://doi.org/10.3109/09273948.2014.971973CrossRefPubMed

Armesto E, Cubillas M, Antón S (2018) Bacterial endogenous endophthalmitis after colonoscopy. Rev Esp Enferm Dig 110:601. https://doi.org/10.17235/reed.2018.5658/2018CrossRefPubMed

Balaskas K, Potamitou D (2009) Endogenous endophthalmitis secondary to bacterial meningitis from Neisseria Meningitidis: a case report and review of the literature. Cases J 2:149CrossRefPubMedPubMedCentral

Bali E, Huyghe P, Caspers L, Libert J (2003) Vitrectomy and silicone oil in the treatment of acute endophthalmitis. Preliminary results. Bull Soc Belge Ophtalmol: 9–14

10.

Behrens-Baumann W, Frank U, Ness T Rational antibiotic therapy in ophthalmology. Ophthalmologe. https://doi.org/10.1007/s00347-009-2077-z

11.

Binder MI, Chua J, Kaiser PK et al (2003) Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine 82:97–105CrossRefPubMed

12.

Bjerrum SS, la Cour M (2017) 59 eyes with endogenous endophthalmitis-causes, outcomes and mortality in a danish population between 2000 and 2016. Graefes Arch Clin Exp Ophthalmol 255:2023–2027. https://doi.org/10.1007/s00417-017-3760-4CrossRefPubMed

13.

Brockhaus L, Goldblum D, Eggenschwiler L et al (2019) Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clin Microbiol Infect 25:1364–1369. https://doi.org/10.1016/j.cmi.2019.01.017CrossRefPubMed

14.

Callegan MC, Engelbert M, Parke DW 2nd et al (2002) Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev 15:111–124CrossRefPubMedPubMedCentral

15.

Chee SP, Jap A (2001) Endogenous endophthalmitis. Curr Opin Ophthalmol 12:464–470. https://doi.org/10.1097/00055735-200112000-00012CrossRefPubMed

16.

Cho H, Shin YU, Siegel NH et al (2018) Endogenous endophthalmitis in the American and Korean population: an 8‑year retrospective study. Ocul Immunol Inflamm 26:496–503. https://doi.org/10.1080/09273948.2016.1195000CrossRefPubMed

17.

Connell PP, O’neill EC, Amirul Islam FM et al (2010) Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center. Retina 30:1721. https://doi.org/10.1097/IAE.0b013e3181dd6db6CrossRefPubMed

18.

Connell PP, O’Neill EC, Fabinyi D et al (2011) Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye 25:66–72. https://doi.org/10.1038/eye.2010.145CrossRefPubMed

19.

Danielescu C, Anton N, Stanca HT, Munteanu M (2020) Endogenous endophthalmitis: a review of case series published between 2011 and 2020. J Ophthalmol 2020:8869590. https://doi.org/10.1155/2020/8869590CrossRefPubMedPubMedCentral

20.

Dave VP, Joseph J, Jayabhasker P et al (2019) Does ophthalmic-grade silicone oil possess antimicrobial properties? J Ophthalmic Inflamm Infect 9:20. https://doi.org/10.1186/s12348-019-0187-6CrossRefPubMedPubMedCentral

21.

Davis JL (2012) Diagnostic dilemmas in retinitis and endophthalmitis. Eye 26:194–201. https://doi.org/10.1038/eye.2011.299CrossRefPubMed

22.

Del Amo EM, Rimpelä A‑K, Heikkinen E et al (2017) Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res 57:134–185. https://doi.org/10.1016/j.preteyeres.2016.12.001CrossRefPubMed

23.

Do T, Hon DN, Aung T et al (2014) Bacterial endogenous endophthalmitis in Vietnam: a randomized controlled trial comparing vitrectomy with silicone oil versus vitrectomy alone. Clin Ophthalmol 8:1633–1640. https://doi.org/10.2147/OPTH.S67589CrossRefPubMedPubMedCentral

24.

Dotrelová D, Dvorák J, Kalvodová B, Stĕpánková J (2003) Pars plana vitrectomy and primary implantation of silicone oil in the treatment of acute exogenous endophthalmitis in eyes without retinal detachment. Cesk Slov Oftalmol 59:146–152PubMed

25.

Durand ML (2017) Bacterial and fungal endophthalmitis. Clin Microbiol Rev 30:597–613. https://doi.org/10.1128/CMR.00113-16CrossRefPubMedPubMedCentral

26.

Eser I, Kapran Z, Altan T et al (2007) The use of blood culture bottles in endophthalmitis. Retina 27:971–973CrossRefPubMed

27.

Gabel-Pfisterer A, Kischio S, Keen M et al (2024) Operative Therapie und Keimnachweis bei endogener Endophthalmitis: eine Datenauswertung aus fünf Augenkliniken. Ophthalmologie. https://doi.org/10.1007/s00347-024-02018-4

28.

Gajdzis M, Figuła K, Kamińska J, Kaczmarek R (2022) Endogenous endophthalmitis-the clinical significance of the primary source of infection. J Clin Med 11:1183. https://doi.org/10.3390/jcm11051183CrossRefPubMedPubMedCentral

29.

Gan IM, van Dissel JT, Beekhuis WH et al (2001) Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis. Br J Ophthalmol 85:1289–1293. https://doi.org/10.1136/bjo.85.11.1289CrossRefPubMedPubMedCentral

30.

Grixti A, Sadri M, Datta AV (2012) Uncommon ophthalmologic disorders in intensive care unit patients. J Crit Care 27(746):e9–e22. https://doi.org/10.1016/j.jcrc.2012.07.013CrossRef

31.

Hirsbein D, Attal P, Gueudry J et al (2008) Endogenous candida endophthalmitis in drug misusers injecting intravenous buprenorphine. J Fr Ophtalmol 31:180–183CrossRefPubMed

32.

Ho DCW, Agarwal A, Lee CS et al (2018) A review of the role of intravitreal corticosteroids as an adjuvant to antibiotics in infectious endophthalmitis. Ocul Immunol Inflamm 26:461–468. https://doi.org/10.1080/09273948.2016.1245758CrossRef

33.

Hsieh M‑C, Chen S‑N, Cheng C‑Y et al (2020) Clinicomicrobiological profile, visual outcome and mortality of culture-proven endogenous endophthalmitis in Taiwan. Sci Rep 10:12481. https://doi.org/10.1038/s41598-020-69251-0CrossRefPubMedPubMedCentral

34.

Hu C‑C, Ho J‑D, Lou H‑Y et al (2012) A one-year follow-up study on the incidence and risk of endophthalmitis after pyogenic liver abscess. Ophthalmology 119:2358–2363. https://doi.org/10.1016/j.ophtha.2012.05.022CrossRefPubMed

35.

Hussain I, Ishrat S, Ho DCW et al (2020) Endogenous endophthalmitis in Klebsiella pneumoniae pyogenic liver abscess: systematic review and meta-analysis. Int J Infect Dis 101:259–268. https://doi.org/10.1016/j.ijid.2020.09.1485CrossRefPubMed

36.

Jackson TL, Eykyn SJ, Graham EM, Stanford MR (2003) Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 48:403–423CrossRefPubMed

37.

Jackson TL, Paraskevopoulos T, Georgalas I (2014) Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol 59:627–635. https://doi.org/10.1016/j.survophthal.2014.06.002CrossRefPubMed

38.

Joondeph BC, Flynn HW Jr, Miller D, Joondeph HC (1989) A new culture method for infectious endophthalmitis. Arch Ophthalmol 107:1334–1337CrossRefPubMed

39.

Kim CH, Chen MF, Coleman AL (2017) Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure. Cochrane Database Syst Rev 2:CD12131. https://doi.org/10.1002/14651858.CD012131.pub2CrossRefPubMed

40.

Kim SJ, Seo SW, Park JM, Chung IY (2009) Bilateral endophthalmitis as the initial presentation of bacterial meningitis. Korean J Ophthalmol 23:321–324CrossRefPubMedPubMedCentral

41.

Lardière-Deguelte S, Ragot E, Amroun K et al (2015) Hepatic abscess: diagnosis and management. J Visc Surg 152:231–243. https://doi.org/10.1016/j.jviscsurg.2015.01.013CrossRefPubMed

42.

Lim HW, Shin JW, Cho HY et al (2014) Endogenous endophthalmitis in the Korean population: a six-year retrospective study. Retina 34:592–602. https://doi.org/10.1097/IAE.0b013e3182a2e705CrossRefPubMed

43.

de Lima LM, Cecchetti SA, Cecchetti DF et al (2012) Endophthalmitis: a rare but devastating metastatic bacterial complication of hemodialysis catheter-related sepsis. Ren Fail 34:119–122. https://doi.org/10.3109/0886022X.2011.623557CrossRefPubMed

44.

Lindstedt EW, Bennebroek CA, van der Werf DJ et al (2014) A prospective multicenter randomized placebo-controlled trial of dexamethasone as an adjuvant in the treatment of postoperative bacterial endophthalmitis: interim safety analysis of the study drug and analysis of overall treatment results. Graefes Arch Clin Exp Ophthalmol 252:1631–1637. https://doi.org/10.1007/s00417-014-2770-8CrossRefPubMed

45.

Lingappan A, Wykoff CC, Albini TA et al (2012) Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol 153:162–166.e1. https://doi.org/10.1016/j.ajo.2011.06.020CrossRefPubMed

46.

Lopez-Cabezas C, Muner DS, Massa MR, Mensa Pueyo JM (2010) Antibiotics in endophthalmitis: microbiological and pharmacokinetic considerations. Curr Clin Pharmacol 5:47–54CrossRefPubMed

47.

Luaces-Rodríguez A, González-Barcia M, Blanco-Teijeiro MJ et al (2018) Review of intraocular pharmacokinetics of anti-infectives commonly used in the treatment of infectious endophthalmitis. Pharmaceutics 10:66. https://doi.org/10.3390/pharmaceutics10020066CrossRefPubMedPubMedCentral

48.

Maling S, King C, Davies N (2018) A british ophthalmological surveillance unit study on metastatic endogenous endophthalmitis. Eye 32:743–748. https://doi.org/10.1038/eye.2017.284CrossRefPubMedPubMedCentral

49.

Manning S, Ugahary LC, Lindstedt EW et al (2018) A prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics. Acta Ophthalmol 96:348–355. https://doi.org/10.1111/aos.13610CrossRefPubMed

50.

Muda R, Vayavari V, Subbiah D et al (2018) Endogenous endophthalmitis: a 9-year retrospective study at a tertiary referral hospital in Malaysia. J Ophthalmic Inflamm Infect 8:14. https://doi.org/10.1186/s12348-018-0158-3CrossRefPubMedPubMedCentral

51.

Ness T (2007) Endogenous endophthalmitis. Ophthalmologe

52.

Neß T (2018) Endophthalmitis. Ophthalmologe 115:697–706. https://doi.org/10.1007/s00347-018-0729-6CrossRefPubMed

53.

Ness T, Bartz-Schmidt KU, Gekeler F, Bartz-Schmidt A (2023) Pathogen identification in endophthalmitis: FRES (Freiburg Endophthalmitis Set) versus standard procedure; a retrospective multicenter comparative study. Investig Ophthalmol Vis Sci 64:615

54.

Ness T, Pelz K (2000) Endophthalmitis: improvement of culture results. Ophthalmologe 97:33–37CrossRefPubMed

55.

Ness T, Pelz K, Hansen LL (2007) Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand 85:852–856CrossRefPubMed

56.

Ness T, Serr A (2008) Diagnostics for endophthalmitis. Klin Monbl Augenheilkd 225:44–49. https://doi.org/10.1055/s-2008-1027132CrossRefPubMed

57.

Nicolle LE (2013) Urinary tract infection. Crit Care Clin 29:699–715. https://doi.org/10.1016/j.ccc.2013.03.014CrossRefPubMed

58.

Okhravi N, Adamson P, Lightman S (2000) Use of PCR in endophthalmitis. Ocul Immunol Inflamm 8:189–200CrossRefPubMed

59.

Ozdamar A, Aras C, Ozturk R et al (1999) In vitro antimicrobial activity of silicone oil against endophthalmitis-causing agents. Retina 19:122–126. https://doi.org/10.1097/00006982-199902000-00006CrossRefPubMed

60.

Palexas GN, Green WR, Goldberg MF, Ding Y (1995) Diagnostic pars plana vitrectomy report of a 21-year retrospective study. Trans Am Ophthalmol Soc 93:281–308 (discussion 308–14)PubMedPubMedCentral

61.

Patel SN, Rescigno RJ, Zarbin MA et al (2014) Endogenous endophthalmitis associated with intravenous drug abuse. Retina 34:1460–1465. https://doi.org/10.1097/IAE.0000000000000084CrossRefPubMed

62.

Pillai GS, Remadevi KK, Anilkumar V et al (2020) Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in south India. Indian J Ophthalmol 68:827–833. https://doi.org/10.4103/ijo.IJO_948_19CrossRefPubMedPubMedCentral

63.

Qureshi A, Ashworth J, Sharma V, Ivanova T (2020) Favourable outcome in paediatric endogenous endophthalmitis secondary to Neisseria meningitidis following pars plana vitrectomy. BMJ Case Rep 13:e233133. https://doi.org/10.1136/bcr-2019-233133CrossRefPubMedPubMedCentral

64.

Rodrigues IAS, Jackson TL (2014) A high-definition view of endogenous fungal endophthalmitis. Lancet Infect Dis 14:358. https://doi.org/10.1016/S1473-3099(13)70216-0CrossRefPubMed

65.

Ruhnke M, Rickerts V, Cornely OA et al (2011) Diagnosis and therapy of candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 54:279–310. https://doi.org/10.1111/j.1439-0507.2011.02040.xCrossRefPubMed

66.

Sadiq MA, Hassan M, Agarwal A et al (2015) Endogenous endophthalmitis: diagnosis, management, and prognosis. J Ophthalmic Inflamm Infect 5:32. https://doi.org/10.1186/s12348-015-0063-yCrossRefPubMedPubMedCentral

67.

Safneck JR (2012) Endophthalmitis: a review of recent trends. Saudi J Ophthalmol 26:181–189. https://doi.org/10.1016/j.sjopt.2012.02.011CrossRefPubMedPubMedCentral

68.

Schiedler V, Scott IU, Flynn HW Jr et al (2004) Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 137:725–731PubMed

69.

Shankar K, Gyanendra L, Hari S, Narayan SD (2009) Culture proven endogenous bacterial endophthalmitis in apparently healthy individuals. Ocul Immunol Inflamm 17:396–399CrossRefPubMed

70.

Sharma S, Padhi TR, Basu S et al (2014) Endophthalmitis patients seen in a tertiary eye care centre in Odisha: a clinico-microbiological analysis. Indian J Med Res 139:91–98PubMedPubMedCentral

71.

Sheu S‑J, Kung Y‑H, Wu T‑T et al (2011) Risk factors for endogenous endophthalmitis secondary to klebsiella pneumoniae liver abscess: 20-year experience in Southern Taiwan. Retina 31:2026–2031. https://doi.org/10.1097/IAE.0b013e31820d3f9eCrossRefPubMed

72.

Sowmya P, Madhavan HN (2009) Diagnostic utility of polymerase chain reaction on intraocular specimens to establish the etiology of infectious endophthalmitis. Eur J Ophthalmol 19:812–817. https://doi.org/10.1177/112067210901900520CrossRefPubMed

73.

Sridhar J, Flynn HW, Kuriyan AE et al (2013) Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect 3:60. https://doi.org/10.1186/1869-5760-3-60CrossRefPubMedPubMedCentral

74.

Sridhar J, Flynn HW, Kuriyan AE et al (2014) Endophthalmitis caused by Klebsiella species. Retina 34:1875–1881. https://doi.org/10.1097/IAE.0000000000000162CrossRefPubMedPubMedCentral

75.

Todokoro D, Mochizuki K, Nishida T et al (2018) Isolates and antibiotic susceptibilities of endogenous bacterial endophthalmitis: a retrospective multicenter study in Japan. J Infect Chemother 24:458–462. https://doi.org/10.1016/j.jiac.2018.01.019CrossRefPubMed

76.

Torii H, Miyata H, Sugisaka E et al (2008) Bilateral endophthalmitis in a patient with bacterial meningitis caused by streptococcus pneumoniae. Ophthalmologica 222:357–359CrossRefPubMed

77.

Uppuluri A, Zarbin MA, Bhagat N (2021) Endogenous endophthalmitis in patients with intravenous opioid use: demographics and associated comorbidities. Int Ophthalmol 41:1513–1520. https://doi.org/10.1007/s10792-021-01709-0CrossRefPubMed

78.

Vilela RC, Vilela L, Vilela P et al (2014) Etiological agents of fungal endophthalmitis: diagnosis and management. Int Ophthalmol 34:707–721. https://doi.org/10.1007/s10792-013-9854-zCrossRefPubMed

79.

Villasmil RJ, Lattanzio N, Burns K, Alkayali T (2021) More than meets the eye: infective endocarditis presenting as endogenous endophthalmitis. Cureus 13:e14745. https://doi.org/10.7759/cureus.14745CrossRefPubMedPubMedCentral

80.

Wadhwani M, Mishra SK, Manika M, Bhartiya S (2020) Metastatic endophthalmitis—has the trend of causative organism changed in the modern antibiotic era—a systematic review. J Ophthalmol 64:105–115

81.

Wang W‑J, Tao Z, Wu H‑L (2018) Etiology and clinical manifestations of bacterial liver abscess: a study of 102 cases. Medicine 97:e12326. https://doi.org/10.1097/MD.0000000000012326CrossRefPubMedPubMedCentral

82.

Wathek C, Rannen R, Wathek C, Rannen R (2016) Ocular manifestations of endocarditis. Contemporary challenges in endocarditis https://doi.org/10.5772/65313CrossRef

83.

Weber C, Stasik I, Herrmann P et al (2023) Early vitrectomy with silicone oil tamponade in the management of postoperative endophthalmitis. J Clin Med 12:5097. https://doi.org/10.3390/jcm12155097CrossRefPubMedPubMedCentral

84.

Wu AY, Oestreicher JH (2011) Endogenous bacterial endophthalmitis after routine colonoscopy. Can J Ophthalmol 46:556–557. https://doi.org/10.1016/j.jcjo.2011.10.002CrossRefPubMed

85.

Wu ZHY, Chan RPS, Luk FOJ et al (2012) Review of clinical features, microbiological spectrum, and treatment outcomes of endogenous endophthalmitis over an 8‑year period. J Ophthalmol 2012:265078. https://doi.org/10.1155/2012/265078CrossRefPubMedPubMedCentral

86.

Yonekawa Y, Chan RV, Reddy AK et al (2011) Early intravitreal treatment of endogenous bacterial endophthalmitis. Clin Experiment Ophthalmol 39:771–778. https://doi.org/10.1111/j.1442-9071.2011.02545.xCrossRefPubMed

87.

Yoshida M, Yokokura S, Nishida T et al (2020) Endogenous endophthalmitis caused by group B streptococcus; case reports and review of 35 reported cases. BMC Ophthalmol 20:126. https://doi.org/10.1186/s12886-020-01378-0CrossRefPubMedPubMedCentral

88.

Yospaiboon Y, Saree S, Pasadhika S (2005) Blood culture and conventional media for vitreous culture in infectious endophthalmitis. J Med Assoc Thai 88:639–642PubMed

89.

Zhang YQ, Wang WJ (2005) Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina 25:746–750CrossRefPubMed

Titel: Bakterielle endogene Endophthalmitis
Erregerspektrum und medikamentöse Therapie
verfasst von: Prof. Dr. Thomas Ness
Publikationsdatum: 04.03.2024
Verlag: Springer Medizin
Schlagwörter: Vitrektomie
Antibiotika
Streptokokken
Escherichia coli
Endokarditis
Sepsis
Sepsis
Erschienen in: Die Ophthalmologie / Ausgabe 4/2024
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-024-01995-w

Passend zum Thema

IPD-Fallzahlen & Pneumokokken-Impfung bei Kindern in Deutschland

Das Niveau der postpandemischen Fallzahlen für invasive Pneumokokken-Erkrankungen (IPD) ist aus Sicht des Referenz-Zentrums für Streptokokken in Aachen alarmierend [1]. Wie sich die monatlichen IPD-Fallzahlen bei Kindern und Jugendlichen von Juli 2015 bis März 2023 entwickelt haben, lesen Sie hier.

HPV-Impfung: Auch für junge Erwachsene sinnvoll und wichtig

Auch nach dem 18. Lebensjahr kann eine HPV-Impfung sinnvoll und wichtig sein. Viele gesetzliche Krankenkassen übernehmen die Kosten auch zu einem späteren Zeitpunkt noch.

Impfstoffe – Krankheiten vorbeugen, bevor sie entstehen

Seit mehr als 130 Jahren entwickelt und produziert MSD Impfstoffe für alle Altersgruppen. Hier finden Sie nützliche Informationen und Praxismaterialien rund um das Thema Impfen.

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2024

Endogene Candida-Endophthalmitis

Endogene Candida-Endophthalmitis: Diagnostik und Therapieoptionen anhand von Fallbeispielen

In Memoriam Dr. med. Rolf Grewe

Hornhaut-Tattoo bei kosmetischer Einschränkung

Katarakt durch iatrogenes Linsentrauma im Rahmen einer intravitrealen Injektion – Darstellung mittels (intraoperativer) optischer Kohärenztomographie

Endogene Endophthalmitis

Passend zum Thema

IPD-Fallzahlen & Pneumokokken-Impfung bei Kindern in Deutschland

HPV-Impfung: Auch für junge Erwachsene sinnvoll und wichtig

Impfstoffe – Krankheiten vorbeugen, bevor sie entstehen